908 research outputs found
Atmospheric pressure gas chromatography-time-of-flight-mass spectrometry (APGC-ToF-MS) for the determination of regulated and emerging contaminants in aqueous samples after stir bar sorptive extraction (SBSE)
This work presents the development, optimization and validation of a multi-residue method for the simultaneous determination of 102 contaminants, including fragrances, UV filters, repellents, endocrine disruptors, biocides, polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and several types of pesticides in aqueous matrices. Water samples were processed using stir bar sorptive extraction (SBSE) after the optimization of several parameters: agitation time, ionic strength, presence of organic modifiers, pH, and volume of the derivatizing agent. Target compounds were extracted from the bars by liquid desorption (LD). Separation, identification and quantification of analytes were carried out by gas chromatography (GC) coupled to time-of-flight (ToF-MS) mass spectrometry. A new ionization source, atmospheric pressure gas chromatography (APGC), was tested. The optimized protocol showed acceptable recovery percentages (50–100%) and limits of detection below 1 ng L−1 for most of the compounds. Occurrence of 21 out of 102 analytes was confirmed in several environmental aquatic matrices, including seawater, sewage effluent, river water and groundwater. Non-target compounds such as organophosphorus flame retardants were also identified in real samples by accurate mass measurement of their molecular ions using GC-APGC–ToF-MS. To the best of our knowledge, this is the first time that this technique has been applied for the analysis of contaminants in aquatic systems. By employing lower energy than the more widely used electron impact ionization (EI), AGPC provides significant advantages over EI for those substances very susceptible to high fragmentation (e.g., fragrances, pyrethroids)
Graph theory-based sequence descriptors as remote homology predictors
Indexación: Scopus.Alignment-free (AF) methodologies have increased in popularity in the last decades as alternative tools to alignment-based (AB) algorithms for performing comparative sequence analyses. They have been especially useful to detect remote homologs within the twilight zone of highly diverse gene/protein families and superfamilies. The most popular alignment-free methodologies, as well as their applications to classification problems, have been described in previous reviews. Despite a new set of graph theory-derived sequence/structural descriptors that have been gaining relevance in the detection of remote homology, they have been omitted as AF predictors when the topic is addressed. Here, we first go over the most popular AF approaches used for detecting homology signals within the twilight zone and then bring out the state-of-the-art tools encoding graph theory-derived sequence/structure descriptors and their success for identifying remote homologs. We also highlight the tendency of integrating AF features/measures with the AB ones, either into the same prediction model or by assembling the predictions from different algorithms using voting/weighting strategies, for improving the detection of remote signals. Lastly, we briefly discuss the efforts made to scale up AB and AF features/measures for the comparison of multiple genomes and proteomes. Alongside the achieved experiences in remote homology detection by both the most popular AF tools and other less known ones, we provide our own using the graphical–numerical methodologies, MARCH-INSIDE, TI2BioP, and ProtDCal. We also present a new Python-based tool (SeqDivA) with a friendly graphical user interface (GUI) for delimiting the twilight zone by using several similar criteria.https://www.mdpi.com/2218-273X/10/1/2
Effects of supply with glutamine on antioxidant system and lipid peroxidation in patients with parenteral nutrition
Introducción: En el paciente crítico hay una continua
producción de especies reactivas de oxígeno (ERO) que
necesitan se neutralizadas para evitar el estrés oxidativo
(EO). Entre las defensas antioxidantes endógenas, el sistema
glutatión (GSH) es cuantitativamente el más importante,
pero en situaciones de estrés severo se encuentra
disminuido. Para incrementarlo, la suplementación con
glutamina ha demostrado ser efectiva, ejerciendo protección
contra el daño oxidativo y reduciendo la morbi-mortalidad.
Objetivo: Valorar el efecto de la adición de un dipéptido
alanyl-glutamina a la NP sobre la peroxidación lipídica
y el metabolismo del glutatión y su relación con la
morbilidad de los pacientes críticos.
Métodos: Determinación, mediante técnicas espectrofotométricas,
de glutatión peroxidasa, glutatión reductasa,
glutatión total y malonilaldehído al ingreso y tras
siete días de estancia en la Unidad de Cuidados Intensivos
(UCI) de 20 pacientes mayores de 18 años con tratamiento
nutricional parenteral.
Resultados: El grupo de pacientes que recibió nutrición
parenteral con adición de glutamina experimentó aumentos
signifcativos a la semana de tratamiento nutricional
en la concentración del glutatión total (42,35 ± 13 vs 55,29
± 12 μmol/l; p < 0,05), junto a un incremento de la actividad
de la enzima glutatión peroxidasa (470 ± 195 vs 705 ±
214 μmol/l; p < 0,05). En cambio, el grupo con nutrición
parenteral convencional no presentó modificaciones significativas
en ninguno de los parámetros estudiados (p >
0,05). Sin embargo, tanto la mortalidad como la estancia en UCI no fue diferente para los grupos estudiados, mientras
que si se observó una menor gravedad, valorada por
e SOFA score, en el grupo de pacientes que recibieron
glutamina (SOFA 5 ± 2 vs 8 ± 1,8; p < 0,05).
Conclusiones: El aporte de glutamina en pacientes críticos
mejora las defensas antioxidantes, lo que repercute
en una menor peroxidación lipídica y menor morbilidad
durante la estancia en UCI.Introduction: In the critically ill patient, there is a
continuous production of reactive oxygen species
(ROS) that need to be neutralized to prevent oxidative
stress (OS). Quantitatively speaking, the glutathione
system (GSH) is the most important anti-oxidant
endogenous defense. To increase it, glutamine supplementation
has been shown to be effective by protecting
against the oxidative damage and reducing the
morbimortality.
Objective: To assess the effect of adding an alanylglutamine
dipeptide to PN on lipid peroxidation lipidica
and glutathione metabolism, as well as its relationship
with morbidity in critically ill patients.
Methods: Determination through spectrophotometry
techniques of glutathione peroxidase, glutathione reductase,
total glutathione, and maloniladdehyde at admission
adn after seven days of hospitalization at the Intensive
Care Unit (ICU) in 20 patients older than 18 years
on parenteral nutrition therapy.
Results: The group of patients receiving parenteral
nutrition with glutamine supplementation had significant
increases in total glutathione (42.35 ± 13 vs 55.29 ±
12 μmol/l; p < 0.05) and the enzymatic activity of glutathione
peroxidasa (470 ± 195 vs 705 ± 214 μmol/l; p <
0.05) within one week of nutritional therapy, whereas
the group on conventional parenteral nutrition did not
show significant changes of any of the parameters studied
(p > 0.05). However, both mortality and ICU stay
were not different between the study group, whereas the
severity (asessed by the SOFA score) was lower in the
group of patients receiving glutamine (SOFA 5 ± 2 vs 8 ±
1.8; p < 0.05).
Conclusions: Glutamine intake in critically ill patients
improves the antioxidant defenses, which leads to lower lipid peroxidation and lower morbidity during admission
at the ICU.Éste estudio ha sido financiado en parte por el
FIBAO y el premio Fressenius/SENPE 2006
European Sea Bass (Dicentrarchus labrax) immune status and disease resistance are impaired by arginine dietary supplementation
Infectious diseases and fish feeds management are probably the major expenses in the aquaculture business. Hence, it is a priority to define sustainable strategies which simultaneously avoid therapeutic procedures and reinforce fish immunity. Currently, one preferred approach is the use of immunostimulants which can be supplemented to the fish diets. Arginine is a versatile amino acid with important mechanisms closely related to the immune response. Aiming at finding out how arginine affects the innate immune status or improve disease resistance of European seabass (Dicentrarchus labrax) against vibriosis, fish were fed two arginine-supplemented diets (1% and 2% arginine supplementation). A third diet meeting arginine requirement level for seabass served as control diet. Following 15 or 29 days of feeding, fish were sampled for blood, spleen and gut to assess cell-mediated immune parameters and immune-related gene expression. At the same time, fish from each dietary group were challenged against Vibrio anguillarum and survival was monitored. Cell-mediated immune parameters such as the extracellular superoxide and nitric oxide decreased in fish fed arginine-supplemented diets. Interleukins and immune-cell marker transcripts were down-regulated by the highest supplementation level. Disease resistance data were in accordance with a generally depressed immune status, with increased susceptibility to vibriosis in fish fed arginine supplemented diets. Altogether, these results suggest a general inhibitory effect of arginine on the immune defences and disease resistance of European seabass. Still, further research will certainly clarify arginine immunomodulation pathways thereby allowing the validation of its potential as a prophylactic strategy.European Union's Seventh Framework Programme AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research) [262336]; AQUAIMPROV [NORTE-07-0124-FEDER-000038]; North Portugal Regional Operational Programme (ON. 2 - O Novo Norte) , under the National Strategic Reference Framework, through the European Regional Development Fund; North Portugal Regional Operational Programme (ON. 2 - O Novo Norte), under the National Strategic Reference Framework through the COMPETE - Operational Competitiveness Programme; Fundacao para a Ciencia e Tecnologia; Fundacao para a Ciencia e Tecnologia [SFRH/BD/89457/2012, SFRH/BPD/77210/2011]; Generalitat Valenciana through the project REVIDPAQUA [ISIC/2012/003]; [PEst-C/MAR/LA0015/2013]; [UID/Multi/04423/2013]info:eu-repo/semantics/publishedVersio
A general piecewise multi-state survival model: Application to breast cancer
Multi-state models are considered in the field of survival analysis for modelling
illnesses that evolve through several stages over time. Multi-state models can be
developed by applying several techniques, such as non-parametric, semi-parametric
and stochastic processes, particularly Markov processes. When the development of
an illness is being analysed, its progression is tracked periodically. Medical reviews
take place at discrete times, and a panel data analysis can be formed. In this paper, a
discrete-time piecewise non-homogeneous Markov process is constructed for
modelling and analysing a multi-state illness with a general number of states. The
model is built, and relevant measures, such as survival function, transition probabilities, mean total times spent in a group of states and the conditional probability of
state change, are determined. A likelihood function is built to estimate the parameters and the general number of cut-points included in the model. Time-dependent
covariates are introduced, the results are obtained in a matrix algebraic form and the
algorithms are shown. The model is applied to analyse the behaviour of breast
cancer. A study of the relapse and survival times of 300 breast cancer patients who
have undergone mastectomy is developed. The results of this paper are implemented
computationally with MATLAB and R.Ministerio de Economía y Competitividad FQM-307European Regional Development Fund (ERDF) MTM2017-88708-PUniversity of Milano-Bicocca 2014-ATE-022
European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
Objective
The best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care.
Design
International multicentre prospective non-interventional registry starting in 2013 aimed to evaluate the decisions and outcomes in H. pylori management by European gastroenterologists. Patients were registered in an e-CRF by AEG-REDCap. Variables included demographics, previous eradication attempts, prescribed treatment, adverse events and outcomes. Data monitoring was performed to ensure data quality. Time-trend and geographical analyses were performed.
Results
30 394 patients from 27 European countries were evaluated and 21 533 (78%) first-line empirical H. pylori treatments were included for analysis. Pretreatment resistance rates were 23% to clarithromycin, 32% to metronidazole and 13% to both. Triple therapy with amoxicillin and clarithromycin was most commonly prescribed (39%), achieving 81.5% modified intention-to-treat eradication rate. Over 90% eradication was obtained only with 10-day bismuth quadruple or 14-day concomitant treatments. Longer treatment duration, higher acid inhibition and compliance were associated with higher eradication rates. Time-trend analysis showed a region-dependent shift in prescriptions including abandoning triple therapies, using higher acid-inhibition and longer treatments, which was associated with an overall effectiveness increase (84%-90%).
Conclusion
Management of H. pylori infection by European gastroenterologists is heterogeneous, suboptimal and discrepant with current recommendations. Only quadruple therapies lasting at least 10 days are able to achieve over 90% eradication rates. European recommendations are being slowly and heterogeneously incorporated into routine clinical practice, which was associated with a corresponding increase in effectiveness
Single hadron response measurement and calorimeter jet energy scale uncertainty with the ATLAS detector at the LHC
The uncertainty on the calorimeter energy response to jets of particles is
derived for the ATLAS experiment at the Large Hadron Collider (LHC). First, the
calorimeter response to single isolated charged hadrons is measured and
compared to the Monte Carlo simulation using proton-proton collisions at
centre-of-mass energies of sqrt(s) = 900 GeV and 7 TeV collected during 2009
and 2010. Then, using the decay of K_s and Lambda particles, the calorimeter
response to specific types of particles (positively and negatively charged
pions, protons, and anti-protons) is measured and compared to the Monte Carlo
predictions. Finally, the jet energy scale uncertainty is determined by
propagating the response uncertainty for single charged and neutral particles
to jets. The response uncertainty is 2-5% for central isolated hadrons and 1-3%
for the final calorimeter jet energy scale.Comment: 24 pages plus author list (36 pages total), 23 figures, 1 table,
submitted to European Physical Journal
Measurement of χ c1 and χ c2 production with s√ = 7 TeV pp collisions at ATLAS
The prompt and non-prompt production cross-sections for the χ c1 and χ c2 charmonium states are measured in pp collisions at s√ = 7 TeV with the ATLAS detector at the LHC using 4.5 fb−1 of integrated luminosity. The χ c states are reconstructed through the radiative decay χ c → J/ψγ (with J/ψ → μ + μ −) where photons are reconstructed from γ → e + e − conversions. The production rate of the χ c2 state relative to the χ c1 state is measured for prompt and non-prompt χ c as a function of J/ψ transverse momentum. The prompt χ c cross-sections are combined with existing measurements of prompt J/ψ production to derive the fraction of prompt J/ψ produced in feed-down from χ c decays. The fractions of χ c1 and χ c2 produced in b-hadron decays are also measured
Measurements of fiducial and differential cross sections for Higgs boson production in the diphoton decay channel at s√=8 TeV with ATLAS
Measurements of fiducial and differential cross sections are presented for Higgs boson production in proton-proton collisions at a centre-of-mass energy of s√=8 TeV. The analysis is performed in the H → γγ decay channel using 20.3 fb−1 of data recorded by the ATLAS experiment at the CERN Large Hadron Collider. The signal is extracted using a fit to the diphoton invariant mass spectrum assuming that the width of the resonance is much smaller than the experimental resolution. The signal yields are corrected for the effects of detector inefficiency and resolution. The pp → H → γγ fiducial cross section is measured to be 43.2 ±9.4(stat.) − 2.9 + 3.2 (syst.) ±1.2(lumi)fb for a Higgs boson of mass 125.4GeV decaying to two isolated photons that have transverse momentum greater than 35% and 25% of the diphoton invariant mass and each with absolute pseudorapidity less than 2.37. Four additional fiducial cross sections and two cross-section limits are presented in phase space regions that test the theoretical modelling of different Higgs boson production mechanisms, or are sensitive to physics beyond the Standard Model. Differential cross sections are also presented, as a function of variables related to the diphoton kinematics and the jet activity produced in the Higgs boson events. The observed spectra are statistically limited but broadly in line with the theoretical expectations
Search for squarks and gluinos in events with isolated leptons, jets and missing transverse momentum at s√=8 TeV with the ATLAS detector
The results of a search for supersymmetry in final states containing at least one isolated lepton (electron or muon), jets and large missing transverse momentum with the ATLAS detector at the Large Hadron Collider are reported. The search is based on proton-proton collision data at a centre-of-mass energy s√=8 TeV collected in 2012, corresponding to an integrated luminosity of 20 fb−1. No significant excess above the Standard Model expectation is observed. Limits are set on supersymmetric particle masses for various supersymmetric models. Depending on the model, the search excludes gluino masses up to 1.32 TeV and squark masses up to 840 GeV. Limits are also set on the parameters of a minimal universal extra dimension model, excluding a compactification radius of 1/R c = 950 GeV for a cut-off scale times radius (ΛR c) of approximately 30
- …